Aβ1-42 promotes microglial activation and apoptosis in the progression of AD by binding to TLR4
Open Access
- 14 November 2024
- journal article
- research article
- Published by Elsevier in Redox Biology
- Vol. 78, 103428
Abstract
No abstract availableKeywords
All Related Versions
This publication has 35 references indexed in Scilit:
- The S1P receptor 1 antagonist Ponesimod reduces TLR4-induced neuroinflammation and increases Aβ clearance in 5XFAD miceEBioMedicine, 2023
- Apoptosis in Alzheimer’s disease: insight into the signaling pathways and therapeutic avenuesApoptosis, 2023
- Alzheimer’s disease: Insights and new prospects in disease pathophysiology, biomarkers and disease-modifying drugsBiochemical Pharmacology, 2023
- 2023 Alzheimer's disease facts and figuresAlzheimer's & Dementia, 2023
- Magnolol improves Alzheimer's disease-like pathologies and cognitive decline by promoting autophagy through activation of the AMPK/mTOR/ULK1 pathwayBiomedicine & Pharmacotherapy, 2023
- Oxymatrine inhibits neuroinflammation by Regulating M1/M2 polarization in N9 microglia through the TLR4/NF-κB pathwayInternational Immunopharmacology, 2021
- NLRP3 inflammasome activation and cell deathCellular & Molecular Immunology, 2021
- Caspase Activation and Caspase-Mediated Cleavage of APP Is Associated with Amyloid β-Protein-Induced Synapse Loss in Alzheimer’s DiseaseCell Reports, 2020
- Apoptotic Caspases: Multiple or Mistaken Identities?Trends in Cell Biology, 2018
- TL-2 attenuates β-amyloid induced neuronal apoptosis through the AKT/GSK-3β/β-catenin pathwayInternational Journal of Neuropsychopharmacology, 2014